Literature DB >> 9460950

Function after subtotal scapulectomy for neoplasm of bone and soft tissue.

C L Gibbons1, R S Bell, J S Wunder, A M Griffin, B O'Sullivan, C N Catton, A M Davis.   

Abstract

We describe the functional results in 14 patients (7 men, 7 women) after subtotal scapulectomy for primary bone and soft-tissue tumours at a specialist musculoskeletal oncology unit. Eight had chondrosarcomas, two Ewing's sarcomas, one aggressive fibromatosis and three soft-tissue sarcomas. The mean follow-up was 52 months (6 to 120). Analysis of residual symptoms and of range and strength of movement by physicians used the Musculoskeletal Tumour Society rating scale (MSTS). Physical disability was measured by the patients using the Toronto Extremity Salvage Score (TESS). All 14 patients are still alive, two with systemic disease. Nine had more than 80% of their scapula resected but the glenohumeral joint was preserved in all cases. Eight had full movement and another two achieved 90 degrees of flexion. The mean functional results were good to excellent in all except three patients (mean MSTS = 71.6 and TESS = 79.9). Two of these three patients had considerable pain as a result of brachial neuropathy. Scapulectomy gives an excellent functional result if the glenohumeral joint is preserved. The rotator cuff could be removed without a severe functional deficit provided that the deltoid was reattached to the scapular remnant and the trapezius.

Entities:  

Mesh:

Year:  1998        PMID: 9460950     DOI: 10.1302/0301-620x.80b1.8183

Source DB:  PubMed          Journal:  J Bone Joint Surg Br        ISSN: 0301-620X


  9 in total

1.  Limb salvage for malignant bone and soft-tissue tumours of the shoulder girdle.

Authors:  Hirofumi Taira; Seiji Yoshida; Mitsuhiro Takasita; Hiroshi Tsumura; Takehiko Torisu
Journal:  Int Orthop       Date:  2003-02-08       Impact factor: 3.075

2.  Reconstruction with scapular hemiarthroplasty endoprosthesis after scapulectomy for malignant tumour.

Authors:  Li Min; Yong Zhou; Fan Tang; Wenli Zhang; Yi Luo; Hong Duan; Chongqi Tu
Journal:  Int Orthop       Date:  2017-03-06       Impact factor: 3.075

3.  The functional and oncological results after scapulectomy for scapular tumours: 2-16-year results.

Authors:  N Mayil Vahanan; P Mohanlal; J C Bose; R Gangadharan; V Karthisundar
Journal:  Int Orthop       Date:  2006-10-17       Impact factor: 3.075

4.  Functional and oncological outcome after surgical resection of the scapula and clavicle for primary chondrosarcoma.

Authors:  S P F T Nota; M J A M Russchen; K A Raskin; H J Mankin; F J Hornicek; J H Schwab
Journal:  Musculoskelet Surg       Date:  2016-11-29

5.  Aggressive Giant Cell Tumor of the Scapula in a 35-Year-Old Woman.

Authors:  Delange Hendrick Augustin; Delange Augustin; Clifford Georges Patrick Khawly; Almenord Pharol; Lerby Exantus
Journal:  Cureus       Date:  2022-05-31

6.  Primary malignant tumours of the scapula--a review of 29 cases.

Authors:  Stephan E Puchner; Joannis Panotopoulos; Rudolf Puchner; Reinhard Schuh; Reinhard Windhager; Philipp T Funovics
Journal:  Int Orthop       Date:  2014-06-25       Impact factor: 3.075

7.  Limb sparing surgery for bone tumours of the shoulder girdle: the oncological and functional results.

Authors:  Qiang Yang; Jianmin Li; Zhiping Yang; Xin Li; Zhenfeng Li
Journal:  Int Orthop       Date:  2009-08-23       Impact factor: 3.075

8.  Experience of total scapular excision for musculoskeletal tumor and reconstruction in eastern Asian countries.

Authors:  Katsuhiro Hayashi; Xiaohui Niu; Xiaodong Tang; Vivek Ajit Singh; Apichat Asavamongkolkul; Akira Kawai; Norio Yamamoto; Toshiharu Shirai; Akihiko Takeuchi; Hiroaki Kimura; Shinji Miwa; Hiroyuki Tsuchiya
Journal:  J Bone Oncol       Date:  2016-10-15       Impact factor: 4.072

Review 9.  Identification and assessment of health-related quality of life issues in patients with sporadic desmoid-type fibromatosis: a literature review and focus group study.

Authors:  Milea J M Timbergen; Lonneke V van de Poll-Franse; Dirk J Grünhagen; Winette T van der Graaf; Stefan Sleijfer; Cornelis Verhoef; Olga Husson
Journal:  Qual Life Res       Date:  2018-07-16       Impact factor: 4.147

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.